Overexpression of JAB1 Promotes Malignant Behavior and Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma

Thoracic Cancer - Australia
doi 10.1111/1759-7714.13350
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Overexpression of VEGF-C and MMP-9 Predicts Poor Prognosis in Kazakh Patients With Esophageal Squamous Cell Carcinoma

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2019English

Down-Regulation of POTEG Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2018English

High MLL2 Expression Predicts Poor Prognosis and Promotes Tumor Progression by Inducing EMT in Esophageal Squamous Cell Carcinoma

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2018English

HOXA13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients With Esophageal Squamous Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2009English

Overexpression of F-Box Only Protein 31 Predicts Poor Prognosis and Deregulates P38α- And JNK-mediated Apoptosis in Esophageal Squamous Cell Carcinoma

International Journal of Cancer
Cancer ResearchOncology
2017English

KDM5B Overexpression Predicts a Poor Prognosis in Patients With Squamous Cell Carcinoma of the Head and Neck

Journal of Cancer
Oncology
2018English

A Molecular Prognostic Model Predicts Esophageal Squamous Cell Carcinoma Prognosis

PLoS ONE
Multidisciplinary
2014English

Overexpression of Stathmin�1 Correlates With Poor Prognosis and Promotes Cell Migration and Proliferation in Oesophageal Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2017English

RACK1 Predicts Poor Prognosis and Regulates Progression of Esophageal Squamous Cell Carcinoma Through Its Epithelial-Mesenchymal Transition

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy